¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

´ëÇѽÅÀåÇÐȸ (¿Â¶óÀÎ) KSN 2020 FULLY VIRTUAL MEETING : 2020-09-26

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
´ëÇѽÅÀåÇÐȸ (¿Â¶óÀÎ) KSN 2020 FULLY VIRTUAL MEETING : 2020-09-26
±³À°ÀÏÀÚ : 2020-09-26
±³À°Àå¼Ò : ¿Â¶óÀÎ ±³À°  
±³À°ÁÖÁ¦ : (¿Â¶óÀÎ) KSN 2020 FULLY VIRTUAL MEETING      
ÁÖÃÖ±â°ü : ´ëÇѽÅÀåÇÐȸ
´ã´çÀÚ : ´ëÇѽÅÀåÇÐȸ
¿¬¶ôó : 02-3486-8736  
À̸ÞÀÏ : ksn@ksn.or.kr      
±³À°Á¾·ù : ³»°úÀÇ»çÇÐ,      
Âü¼®¿¹»óÀοø : 2000¸í
Èñ¸ÁÆòÁ¡ : 6Á¡ (ÀÏ¹Ý 4Á¡ / Çʼö 2Á¡)  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 10 ½Ã°£ 0ºÐ  
¼¼ºÎ¼ö°­·á : 100,000¿ø      
ºñ°í »çÀüµî·Ï : ȸ¿ø:50,000¿ø/ºñȸ¿ø:75,000/Fellow-in-training,Resident,Trainee,Student,Nurse,etc:25,000 ´çÀϵî·Ï : ȸ¿ø:75,000¿ø/ºñȸ¿ø:100,000/Fellow-in-training,Resident,Trainee,Student,Nurse,etc:35,000      
       
±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 09¿ù 26ÀÏ ¿Â¶óÀΠ08:30~09:00 New risk factors to chronic kidney disease  ÇѽÂÇõ(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 09¿ù 26ÀÏ ¿Â¶óÀΠ09:00~09:30 Mechanisms of tissue inflammation and injury in the kidney  Mary E. Choi(Cornell Univ USA) 
±³À°½Ã°£ 09¿ù 26ÀÏ ¿Â¶óÀΠ09:30~10:00 Update of management of vasculitis  Stephen P. McAdoo(Imperial College UK) 
±³À°½Ã°£ 09¿ù 26ÀÏ ¿Â¶óÀΠ10:00~10:30 Overview of Transplant Immunology  Michelle Josephson(University of ChicagoUSA) 
±³À°½Ã°£ 09¿ù 26ÀÏ ¿Â¶óÀΠ10:30~11:00 Clinical impact of complement binding assay  ±è¸í±Ô(°í·ÁÀÇ´ë) 
±³À°½Ã°£ 09¿ù 26ÀÏ ¿Â¶óÀΠ11:00~11:30 Biomarker of acute rejection  ÀÌ»óÈ£(°æÈñÀÇ´ë) 
±³À°½Ã°£ 09¿ù 26ÀÏ ¿Â¶óÀΠ11:30~12:00 Clinical application of HLA epitopes  ¿ÀÀºÁö(°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 09¿ù 26ÀÏ ¿Â¶óÀΠ12:00~12:50 HDx, designed to be different for improving patient outcomes (draft)  ¼Û»óÇå(ºÎ»êÀÇ´ë) 
±³À°½Ã°£ 09¿ù 26ÀÏ ¿Â¶óÀΠ12:50~13:40 Novel Treatment Option of Hyperphosphatemia ? Velphoro  °­ÀÌÈ­(±¹¹Î°Ç°­º¸Çè Àϻ꺴¿ø) 
±³À°½Ã°£ 09¿ù 26ÀÏ ¿Â¶óÀΠ14:00~14:50 Polycystic Kidney Disease: New Molecular Mechanisms and Therapeutic Targets  Michael Caplan(USA) 
±³À°½Ã°£ 09¿ù 26ÀÏ ¿Â¶óÀΠ15:00~15:30 Blood Pressure and Volume Management in HD  Angela Wang(The University of Hong Kong Hong Kong) 
±³À°½Ã°£ 09¿ù 26ÀÏ ¿Â¶óÀΠ15:30~16:00 Blood pressure measurement and assessment of volume status in hemodialysis patients  Á¤Á¾Ã¶(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 09¿ù 26ÀÏ ¿Â¶óÀΠ16:00~16:30 Lipids and Obesity in CKD  Sydney Tang(The University of Hong Kong Hong Kong) 
±³À°½Ã°£ 09¿ù 26ÀÏ ¿Â¶óÀΠ16:30~17:00 Lipids and Obesity in CKD: Results from KNOW-CKD and Recent Trends in Treatment  ÇѽÂÇõ(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 09¿ù 26ÀÏ ¿Â¶óÀΠ17:00~17:30 Guideline for Preventing of Infections in HD Centers  ÀÌÀç°©(ÇѸ²ÀÇ´ë) 
±³À°½Ã°£ 09¿ù 26ÀÏ ¿Â¶óÀΠ17:30~18:00 Medical ethics in the social media era  ±è±â¿ø(±¹¸³¾Ï¼¾ÅÍ) 
±³À°½Ã°£ 09¿ù 26ÀÏ ¿Â¶óÀΠ18:00~18:20 Autonomy and Self-determination: A decision aid for ESRD patients  ¾È¼øÅÂ(ÀÌÈ­¿©´ë) 
±³À°½Ã°£ 09¿ù 26ÀÏ ¿Â¶óÀΠ18:20~18:40 Shared Decision Making: Educational Support Around Dialysis Modality Decision Making and its applications  ±è¼¼Áß(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 09¿ù 26ÀÏ ¿Â¶óÀΠ18:40~19:00 Autonomy and paternalism in peritoneal dialysis patients: home-care demonstration project  ±è¿ëö(¼­¿ïÀÇ´ë) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ´ëÇѽÅÀåÇÐȸ (¿Â¶óÀÎ) KSN 2020 FULLY VIRTUAL MEETING : 2020-09-26""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ¿µ³²´ëÇб³º´¿ø Á¦5ȸ ¿µ³²±Û·Î¹úºñ´¢ÀÇÇÐ ½ÉÆ÷Áö¾ö : 2020-09-26
´ÙÀ½±Û ´ëÇÑÀ̺ñÀÎÈÄ°úÇÐȸ ºÎ»ê¡¤¿ï»ê¡¤°æ³² ÁöºÎȸ 2020³â 9¿ù Çмú´ëȸ : 2020-09-26
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20544 ¼­¿ï 2024 Çѱ¹¸ðÀÚº¸°ÇÇÐȸ Á¦54ȸ Ãá°è¿¬¼ö°­Á : 2024-05-25 0 28 2024-04-29
20543 ¼­¿ï Çѱ¹ÀÇ·áÀ±¸®ÇÐȸ Áö¿ª»çȸ ±â¹Ý ÀÇ·á¿Í À±¸®¿ª·® °­È­ : 2024-05-25 0 34 2024-04-29
20542 °­¿ø Á¦31Â÷ ´ëÇѽŰæ¼Õ»óÇÐȸ Á¤±âÇмú´ëȸ : 2024-05-25 0 55 2024-04-29
20541 Ãæ³² Á¦4ȸ ´ëÇѺñ¸¸ÇÐȸ ÃæûÁöȸ ¿¬¼ö°­Á : 2024-05-25 0 79 2024-04-29
20540 ¼­¿ï ´ëÇѳúÀüÁõÇÐȸ ¿¬ÇÕ ½ÉÆ÷Áö¾ö : 2024-05-25 0 49 2024-04-29
20539 ¼­¿ï 2024 ÀÎÁöÁßÀçÄ¡·áÇÐȸ Ãá°è Çмú´ëȸ : 2024-05-25 0 51 2024-04-29
20538 ¼­¿ï Á¦8ȸ °­µ¿°æÈñ´ëÇб³º´¿ø ÀÓ»óÀǸ¦ À§ÇÑ ½Å°æ°ú ¿¬¼ö°­Á : 2024-05-25 0 51 2024-04-29
20537 °æºÏ 2024³âµµ °æ»óºÏµµÀÇ»çȸ Á¾ÇÕÇмú´ëȸ(1ÀÏÂ÷) : 2024-05-25 0 49 2024-04-29
20536 ¼­¿ï (¿Â¶óÀÎ)2024³â ´ëÇÑ°ñ´ë»çÇÐȸ Á¦1Â÷ FLS ÄÚµð³×ÀÌÅÍ ¿öÅ©¼ó : 2024-05-24 0 62 2024-04-29
20535 Àü³² Á¦56ȸ ´ëÇѼҾƽŰæÇÐȸ Ãá°èÇмú´ëȸ day 2 : 2024-05-24 0 48 2024-04-29
20534 ¼­¿ï (¿Â¶óÀÎ) ÀÇ·á±â°ü Á¾»çÀÚ ´ë»ó ¿¬¸íÀÇ·á°áÁ¤Á¦µµ ±âº»±³À° : 2024-05-24 0 40 2024-04-29
20533 ¼­¿ï (¿Â¶óÀÎ) ÀÇ·á±â°ü Á¾»çÀÚ(À§¿øȸ) ´ë»ó ¿¬¸íÀÇ·á°áÁ¤Á¦µµ ½ÉÈ­±³À° : 2024-05-24 0 42 2024-04-29
20532 Àü³² 2024³â ¼øõ½ÃÀÇ»çȸ Ãá°èÇмú´ëȸ(ºÎÁ¤¸Æ, ¾Ë·¹¸£±â ¸é¿ª¿ä¹ý) : 2024-05-23 0 58 2024-04-29
20531 Àü³² Á¦56ȸ ´ëÇѼҾƽŰæÇÐȸ Ãá°èÇмú´ëȸ : 2024-05-23 0 60 2024-04-29
20530 ¼­¿ï ¿¡ÀÌÄ¡Ç÷¯½º¾çÁöº´¿ø Á¦2024-1ȸ ¿¬¼ö°­Á : 2024-05-23 0 48 2024-04-29
11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷